HCV infection is usually diagnosed by means of an enzyme immune assay for the detection of antibody against HCV. The window period between infection and seroconversion remains a dramatic problem in the transfusional and diagnostic setting. In this chapter, we report (i) procedures for assays using two different approaches designed to reduce the window period and (ii) performance in terms of specificity and sensitivity in the detection of both antibody and antigen, and we compare their efficacy with that of commercial assays.
CITATION STYLE
Ansaldi, F., & Icardi, G. (2009). Simultaneous detection of anti-HCV antibody and HCV core antigen. Methods in Molecular Biology (Clifton, N.J.), 510, 15–23. https://doi.org/10.1007/978-1-59745-394-3_2
Mendeley helps you to discover research relevant for your work.